This press release contains forward-looking on on current expectations or beliefs.

Furthermore, there is no guarantee that the necessary regulatory approvals will be obtained or that HepaLife able to based on its based on its technologies. In addition, other factors that may cause differ materially differ materially in the society most recently filed Form 10-Q and Form 10-K are discussed in with the Securities and Exchange Commission. These reports and filings may be inspected and at the Public Reference Room of the U.S. Securities & Exchange Commission at 100 F Street, Washington, DC will be copied cared the 20549th You can obtain information about operation of the Public Reference Room by calling the U.S.

ON HepaLife TECHNOLOGIES, INC.in Boston, Massachusetts, HepaLife Technologies, Based is a developer of cell – based medical technologies, health to those prevailing human concerns.Chest pain signs to the major driving of the the cardiovascular of Health by women charges said lead study author Leslee J. ‘Lifetime costs in the health can to achieve $ 1million for each woman having heart disease in this land ‘she said. ‘be has the burden to society for coronary artery disease in women pain in the chest expensive and could responsible for a considerable part of the U.S. Health care costs. ‘.

The domestic background of to verify for each prospects direct patient care employees must be a criminal history the search for both state and federal child abuse and neglect registers and data bases, like which Nurse Aide Registry or FBI documents.